guanfacine hydrochloride extended-release (AM/PM once-daily)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for guanfacine hydrochloride extended-release (AM/PM once-daily), covering 2011-10-26 to 2011-10-26. Get the full timeline:
Most recent: Clinical Trial Update: Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study) [Phase 3]